Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ERAP2 | Q6P179 | 4/20 | 0.61 |
| ▸ | MMP2 | P08253 | 3/20 | 0.55 |
| ▸ | MMP1 | P03956 | 3/20 | 0.55 |
| ▸ | MMP9 | P14780 | 3/20 | 0.55 |
| ▸ | MMP8 | P22894 | 3/20 | 0.55 |
| ▸ | ACE | P12821 | 2/20 | 0.55 |
| ▸ | ECE1 | P42892 | 4/20 | 0.54 |
| ▸ | IL1RN | P18510 | 3/20 | 0.53 |
| ▸ | ERAP1 | Q9NZ08 | 2/20 | 0.53 |
| ▸ | MMP3 | P08254 | 1/20 | 0.52 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.52 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.51 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.51 |
| ▸ | GHSR | Q92847 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30830320 | 0.97 | ERAP2 (0.58) | ERAP2MMP2MMP1MMP9MMP8 | |
| SCHEMBL29531509 | 0.93 | ERAP2 (0.65) | ERAP2MMP2MMP1MMP9MMP8 | |
| SCHEMBL30567418 | 0.93 | ERAP2 (0.65) | ERAP2MMP2MMP1MMP9MMP8 | |
| SCHEMBL30799750 | 0.93 | MMP9 (0.59) | ERAP2MMP2MMP1MMP9MMP8 | |
| SCHEMBL30788012 | 0.90 | ERAP2 (0.64) | ERAP2MMP2MMP1MMP9MMP8 | |
| SCHEMBL31720529 | 0.89 | ERAP2 (0.74) | ERAP2MMP2MMP1MMP9MMP8 | |
| SCHEMBL30799516 | 0.89 | CCKBR (0.57) | ERAP2ERBB2OPRD1GHSR | |
| SCHEMBL29828471 | 0.89 | KDM4E (0.59) | ERAP2MMP2MMP1MMP9MMP8 | |
| SCHEMBL30620990 | 0.88 | ERAP2 (0.72) | ERAP2MMP2MMP1MMP9MMP8 | |
| SCHEMBL9799753 | 0.88 | ERAP2 (0.67) | ERAP2ACEECE1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11807899-B2 | Biochemical reaction methods and reagents comprising intrinsically disordered regions | Biocrucible Limited | 2023-11-07 | — | — | US | disclosed |
| US-20220145378-A1 | BIOCHEMICAL REACTION METHODS AND REAGENTS COMPRISING INTRINSICALLY DISORDERED REGIONS | Biocrucible Limited (GB) | 2022-05-12 | — | — | US | disclosed |